Ptosis drug FDA Approved

July 10, 2020
Ptosis-2.1.jpg

We are excited to announce another FDA approved drug that was tested at ENCORE Research Group’s Nature Coast Clinical Research office In Crystal River Florida. Upneeq™, is a drug to help adults with blepharoptosis, or ptosis, which is a condition where there is an abnormal drooping of the upper eyelid causing a loss in vision. Upneeq™ is currently the only FDA approved medical treatment for drooping eyelids (ptosis).

 

For more information about this, view the full press release here:

https://www.osmotica.com/

 

Copyright 2023 ENCORE Research Group